Videographic Feedback and Walk Rehabilitation in Post-Cerebrovascular Accident

Cerebrovascular Accident Clinical Trial

— CoDévi  

Official title:

Videographic Feedback and Walk Rehabilitation in Post-Cerebrovascular Accident

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05024981
• Other study ID #: 19-GIRCI-02
• Status: Recruiting
• Phase: N/A
• Start date: March 4, 2022
• Est. completion date: December 15, 2024

Study information

• Verified date: June 2023
• Source: Centre Hospitalier Universitaire de Nice
• Contact: Audrey MARTEU
• Phone: 4 92 03 40 80
• Email: marteu.a[@]chu-nice.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Cerebrovascular Accident affects the majority of the elderly population and its frequency is constantly increasing. The resulting deficits are numerous and lead in particular to an alteration in the quality of walking and autonomy. Numerous rehabilitation techniques have been described. In practice, correction instructions are often given by the therapist while the motor activity is being performed. Walking is a complex activity, as is the processing of dual-task information in elderly stroke patients. It therefore appears interesting to separate the time of motor realization and that of correction instructions. Investigators therefore propose firstly to film the patient during the performance of a walking activity and then, secondly, to analyse the video with the patient, which thus represents a source of delayed feedback. The main objective of the study is to observe the effects of this practice on walking speed. Investigators are comparing two groups of patients: the control group receiving conventional rehabilitation and the experimental group receiving conventional rehabilitation plus sessions with the video tool. They expect to observe a greater improvement in walking speed in the experimental group.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 64
• Est. completion date: December 15, 2024
• Est. primary completion date: September 15, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 70 Years and older

Eligibility

Inclusion Criteria:

• Hospitalization for a first episode of Cerebrovascular Accident less than six months old, or nth stroke less than six months old, with no previous sequelae;

• Able to walk at least 10m without stopping, with or without technical assistance, but without human assistance, under supervision;

Exclusion Criteria:

• Palliative or life-threatening situation;

• A patient whose guardian or trustee is not readily available to provide information about the patient

• Neuro-cognitive disorder that prevents understanding of instructions, as determined by the clinician;

• Severe speech or language disorder that prevents the protocol from being carried out correctly;

• Hemineglect;

• Any previously known pathology altering the gait pattern, at the clinician's discretion (recent neurological, traumatological or orthopaedic pathologies, etc.);

• Visual disorder preventing viewing of the video;

• Hearing disorder preventing comprehension.

Related Conditions & MeSH terms

• Cerebrovascular Accident
• Stroke

Intervention

Behavioral:
• Videographic feedback
Twice a week during his classic re-education sessions, the patient will be filmed for 1 minute. After transferring the video to a tablet, he will watch the video once and decide what he wants to correct. During the second viewing, he will analyse his walk, the therapist being present to provide additional information. Finally, the patient will apply his analysis while being filmed and will compare the possible differences between the 2 videos. Depending on the time available, the patient may have to repeat the recordings, analyses and exercises.
• Classic reeducation
The patient will benefit twice a day for 30 minutes from re-education sessions.

Locations

Country	Name	City	State
France	CHU Nice	Nice	Alpes-Maritime

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Walking speed	Difference in walking speed between the initial and final assessment in each group.	Day 26